Aldevron Adds DasherGFP® mRNA to its Product Portfolio
February 12, 2020 10:30 ET | Aldevron
Fargo, N.D., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins, mRNA and antibodies for the biotech industry, announced...
Aldevron Plasmids Used to Support Calviri’s Clinical Trial of a Vaccine Against Canine Cancer
December 03, 2019 09:51 ET | Aldevron
TEMPE, A.Z. and FARGO, N.D., Dec. 03, 2019 (GLOBE NEWSWIRE) -- Prevention of cancer onset is the ultimate aspiration for animals and humans. Cancer is caused by mutations that are specific to the...
Aldevron Names Michelle Berg President of GMP Business Unit
May 21, 2019 07:30 ET | Aldevron
Fargo, North Dakota, May 21, 2019 (GLOBE NEWSWIRE) -- Aldevron, a leader in the production of plasmid DNA, proteins, mRNA and antibodies, has expanded its leadership team by appointing Michelle Berg...
Aldevron Announces 1,000 Liter Fermentation Capacity and Significant Manufacturing Space Expansion
April 30, 2019 06:30 ET | Aldevron
Fargo, ND, April 30, 2019 (GLOBE NEWSWIRE) -- Aldevron announced today its new fermentation capacity of 1,000 liters and plans to significantly increase the Company’s manufacturing footprint in...
Aldevron Releases GMP-Grade SpyFi™ Cas9 Nuclease
March 12, 2019 08:05 ET | Aldevron
FARGO, ND, March 12, 2019 (GLOBE NEWSWIRE) -- Aldevron, a leading contract development and manufacturing organization serving the biotech industry, announces the release of GMP SpyFi Cas9 Nuclease...